Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA approves new pain medicine
What to Know About Journavx, the Non-Opioid Pain Medication Just Approved by the FDA
The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in more than 20 years.
FDA approves new pain medicine as opioid alternative. What to know about Journavx
The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side effects.
FDA approves new pain medication as an alternative to opioids: What to know about Journavx
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.
BioPharma Dive
4h
A new, non-opioid pain drug is here. Getting it to patients could be agony.
After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...
Psychology Today
3h
Treating Pain—Avoiding the Brain
A new class of non-opioid drugs treats pain by blocking signals before they reach the brain, reducing the risk of addiction.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Black boxes recovered
New tariffs coming Saturday
IL won’t hire Jan. 6 rioters
Todd exits NBC News
Tour boat captain sentenced
Cause of death revealed
Cancerous tumor removed
Apologizes for old tweets
Activists call for boycott
Granted legal personhood
Top leaders asked to resign
Navajo men, partner indicted
Inmate's transfer blocked
Searching for joyriders
Shiffrin finishes 10th
Recuses self from Act 10 suit
Michigan priest loses license
Olympic gold medalist dies
Hamas confirms death
2 more victims in indictment
US inflation ticked higher
To raise hourly pay
'As Tears Go By' singer dies
Partners w/ US national labs
Nashville bids for franchise
FDA approves painkiller
S3 release date revealed
DOJ sues to block deal
Weekly jobless claims fall
Feedback